prsv rev dull (Addgene inc)
Addgene inc is a verified supplier 
96
Structured Review
Addgene inc
prsv rev dull
Prsv Rev Dull, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1588 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prsv+rev+plasmid/pRSV-Rev+(Plasmid+%2312253)/pm41875887-830-107-111
Average 96 stars, based on 1588 article reviews
Prsv Rev Dull, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1588 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prsv+rev+plasmid/pRSV-Rev+(Plasmid+%2312253)/pm41875887-830-107-111
Average 96 stars, based on 1588 article reviews
prsv rev dull - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: Detection of fumarate-derived modification in a test sample Article Snippet: 5-puro non-mammalian shRNA control plasmids (Sigma-Aldrich, St. Louis, MO) were used to generate the lentiviral vectors. .. 15 μg vector plasmid, 10 μg psPAX2 packaging plasmid (Addgene 12260, Cambridge, MA), 5 μg pMD2.G envelope plasmid (Addgene 12259, Cambridge, MA) and 2.5 μg Article Title: SNCA -targeted epigenome therapy for Parkinson’s disease alleviates pathological and behavioral perturbations in a mouse model Article Snippet: .. Briefly, 15 μg vector plasmid, 10 μg psPAX2 packaging plasmid (Addgene 12260 generated in Dr. Didier Trono’s lab, EPFL, Switzerland), 5 μg pMD2.G envelope plasmid (Addgene 12259, generated in Dr. Trono’s lab), and 2.5 μg Article Title: CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes Article Snippet: .. Briefly, 15 μg of vector plasmid, 10 μg of psPAX2 packaging plasmid (Addgene #12260 generated in Dr Didier Trono’s laboratory, EPFL, Switzerland), 5 μg of pMD2.G envelope plasmid (Addgene #12259, generated in Dr Trono’s laboratory) and 2.5 μg of Article Title: CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer. Article Snippet: .. We used 2.8 μg pMDLg/pRRE plasmid (Addgene plasmid #12,251;; RRID:Addgene_12251), 1.4 μg Article Title: DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer Article Snippet: .. The pMDLg/pRRE plasmid (#12251), pMD2.g 46 plasmid (#12259) and Article Title: CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer Article Snippet: .. We used 2.8 μg pMDLg/pRRE plasmid (Addgene plasmid #12,251;; RRID:Addgene_12251), 1.4 μg Transfection:Article Title: Detection of fumarate-derived modification in a test sample Article Snippet: 5-puro non-mammalian shRNA control plasmids (Sigma-Aldrich, St. Louis, MO) were used to generate the lentiviral vectors. .. 15 μg vector plasmid, 10 μg psPAX2 packaging plasmid (Addgene 12260, Cambridge, MA), 5 μg pMD2.G envelope plasmid (Addgene 12259, Cambridge, MA) and 2.5 μg Article Title: SNCA -targeted epigenome therapy for Parkinson’s disease alleviates pathological and behavioral perturbations in a mouse model Article Snippet: .. Briefly, 15 μg vector plasmid, 10 μg psPAX2 packaging plasmid (Addgene 12260 generated in Dr. Didier Trono’s lab, EPFL, Switzerland), 5 μg pMD2.G envelope plasmid (Addgene 12259, generated in Dr. Trono’s lab), and 2.5 μg Article Title: CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes Article Snippet: .. Briefly, 15 μg of vector plasmid, 10 μg of psPAX2 packaging plasmid (Addgene #12260 generated in Dr Didier Trono’s laboratory, EPFL, Switzerland), 5 μg of pMD2.G envelope plasmid (Addgene #12259, generated in Dr Trono’s laboratory) and 2.5 μg of Article Title: CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer. Article Snippet: .. We used 2.8 μg pMDLg/pRRE plasmid (Addgene plasmid #12,251;; RRID:Addgene_12251), 1.4 μg Article Title: CRISPR/Cas9 Screening Highlights PFKFB3 Gene as a Major Contributor to 5-Fluorouracil Resistance in Esophageal Cancer Article Snippet: .. We used 2.8 μg pMDLg/pRRE plasmid (Addgene plasmid #12,251;; RRID:Addgene_12251), 1.4 μg Generated:Article Title: SNCA -targeted epigenome therapy for Parkinson’s disease alleviates pathological and behavioral perturbations in a mouse model Article Snippet: .. Briefly, 15 μg vector plasmid, 10 μg psPAX2 packaging plasmid (Addgene 12260 generated in Dr. Didier Trono’s lab, EPFL, Switzerland), 5 μg pMD2.G envelope plasmid (Addgene 12259, generated in Dr. Trono’s lab), and 2.5 μg Article Title: CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes Article Snippet: .. Briefly, 15 μg of vector plasmid, 10 μg of psPAX2 packaging plasmid (Addgene #12260 generated in Dr Didier Trono’s laboratory, EPFL, Switzerland), 5 μg of pMD2.G envelope plasmid (Addgene #12259, generated in Dr Trono’s laboratory) and 2.5 μg of other:Article Title: A NAPE–LRRK2 metabolic axis controls lysosomal homeostasis in Parkinson’s disease Article Snippet: Lentiviral particles were produced by transient transfection of HEK293T cells using polyethyleneimine (PEI) (Sigma, #306185). |